Skip to content

Palmar-Plantar Erythrodysesthesia

Last updated: 29 May 2024
1/2
  1. Palmar-Plantar Erythrodysesthesia
  2. Palmer Plantar Grading Scale PPE (adapted NCI CTCAE)
Palmar-Plantar Erythrodysesthesia

Palmar-Plantar Erythrodysesthesia

Palmar-Plantar Erythrodysesthesia (PPE) is a dermatologic toxicity associated with a number of chemotherapeutic drugs and some kinase inhibitors. Also known as Hand-Foot Syndrome (HFS), it is characterised by tingling and tenderness developing to symmetrical redness, swelling, and pain primarily on the palm of the hand and sole of the foot.

Palmar-plantar erythrodysesthesia associated with chemotherapy and its treatment by K. P. Farr and A. Safwat is licensed under CC BY-NC-ND 3.0.
View larger
View larger

Palmer Plantar Grading Scale PPE (adapted NCI CTCAE)

Grade 1

(Mild)

Grade 2

(Moderate)

Grade 3

(Severe)

Minimal skin changes or dermatitis (e.g.

erythema, oedema, or

hyperkeratosis) without pain

Skin changes (e.g.

peeling, blisters,

bleeding, oedema, or

hyperkeratosis) with

pain; limiting self-care

activities of daily living (ADLs)

Severe skin changes (e.g. peeling, blisters, bleeding, oedema, or

hyperkeratosis) with

pain; limiting self-care

ADLs

Grade 1 (Mild) – Non Urgent

Patient Management

● Prevention, support, teaching, & follow-up as required

● Skin Care

- Before any symptoms develop liberal use of NON-urea based creams regularly to soften the skin.

Avoid alcohol-based products.

Skin care considerations:

- Avoid sun exposure during treatment – use sun block

- Avoid contact with harsh chemicals – use non - rubberised protective gloves.

- Avoid using hands for activities that might cause abrasion.

- Avoid exposure to hot water. Clean hands, feet with lukewarm water and gently pat dry.

- Promote adequate hydration/nutrition during treatment to help prevent skin dryness or

desquamation.

● Pharmacological Management

- Collaborate with clinician / team.

- Pharmacological management (e.g. topical application of emollient urea 10%).

● Patient Education and Follow-Up

- Encourage daily self-assessment of skin

- Early signs of PPE – tingling and numbness, areas of dry furrowed skin with any changes in

pigmentation.

- When to seek immediate medical attention:

- Temperature greater than or equal to 38°C and/or presence of redness, discharge or odour from open areas

- When unable to perform ADLs

  • When pain is not controlled.

Grade 2 (Moderate) - Urgent

● Requires medical attention within 24 hours

● Collaborate with clinician / team

- Treatment delays, reductions or discontinuation of treatment.

- Management of skin complications

- Pharmacological management (e.g. pain management – topical or oral, antibiotics if infection

Identified).

- Patient education and follow-up (as previous step)

Grade 3 (Severe) - Emergency

● Requires IMMEDIATE medical attention

● Patients will generally require hospital admission

● Notify clinician / team of ABC CNS assessment

● Notify Emergency Department

Was this article helpful?

Suggest an edit

Suggest an edit

Would additional content be helpful on this page? Email suggestions and feedback to intouch@bcf.org.nz. Thank you.

This field is optional
(e.g.+6421 000 0000)